Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Novartis AG ADS
(NY:
NVS
)
71.90
USD
-1.22 (-1.67%)
Official Closing Price
/ Updated:
6:40 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Novartis AG ADS
< Previous
1
2
...
65
66
67
68
69
70
71
72
Next >
Novartis (NVS) NewsBite - NVS Higher On Alcon Acquisition Update
July 08, 2008
Novartis (NVS) opened at $57.49. So far today the stock has hit a low of $57.40 and a high of $57.505. NVS is now trading at $57.40, up 1.45 (2.59%). After hitting a one-year high of $59.17 in January,...
Read More
category
NVS,ACL
from
MarketIntelligenceCenter.com
Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
July 01, 2008
Jury verdict in Montgomery County Circuit Court awards $33 million in compensatory damages Jury decides in favor of Novartis and rejects claims for punitive damages NPC maintains it reported true and...
Read More
category
Health Care
from
FOXBusiness.com
Emisphere (EMIS) Announces Launch of Phase I PTH134 Combination Study
June 30, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3780060 for the full story.
Read More
from
StreetInsider.com News Articles
Novartis AG (NVS) NewsBite - Upgrade Boosts NVS
June 24, 2008
Novartis AG (NVS) opened at $53.23. So far today the stock has hit a low of $53.23 and a high of $53.45. NVS is now trading at $53.35, up 1.76 (3.42%). After hitting a one-year high of $59.17 in...
Read More
category
NVS
from
MarketIntelligenceCenter.com
U.K. Health Service To Get 5% Discount On Branded Drugs
June 18, 2008
U.K. Health Service To Get 5% Discount On Branded Drugs
Read More
category
Health Care
from
FOXBusiness.com
Teva Pharmaceutical (TEVA) Receives Tentative FDA Approval for Generic Diovan
June 12, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3738579 for the full story.
Read More
from
StreetInsider.com News Articles
HSBC Downgrades Novartis (NVS) to Underweight
June 12, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3737594 for the full story.
Read More
from
StreetInsider.com News Articles
Novartis AG (NVS) NewsBite
June 05, 2008
Novartis AG ( NYSE: NVS ) closed yesterday at $52.40. So far the stock has hit a 52-week low of $46.19 and 52-week high of $59.17. Novartis AG stock has been showing support around 52.03 and resistance...
Read More
category
NVS
from
MarketIntelligenceCenter.com
Notable Mergers and Acquisitions of the Day 6/4 (SJM/PG, NVS, GD/HLTH, IACI)
June 04, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3714614 for the full story.
Read More
from
StreetInsider.com News Articles
Novartis (NVS) Buys Protez Pharma for Up to $400M
June 04, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3714067 for the full story.
Read More
from
StreetInsider.com News Articles
Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
May 19, 2008
Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
Read More
category
Health Care
from
FOXBusiness.com
Novartis Reports Progress With a Cancer Treatment
May 19, 2008
Novartis Reports Progress With a Cancer Treatment
Read More
category
Health Care
from
FOXBusiness.com
RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
May 19, 2008
- RECORD-1 trial shows RAD001 reduces risk of disease progression by 70% - RAD001 is first and only drug to show significant benefit after failure of approved therapies Sutent(R) or Nexavar(R),** with...
Read More
category
Health Care
from
FOXBusiness.com
Meet Teva, The Generic Giant
May 15, 2008
Success in generic drugs is all about high volume, low prices and global presence. Israel's Teva Pharmaceuticals has all three.
Read More
from
Investopedia Advisor Commentary
Novartis (NVS) NewsBite - IMS Health Report Boosts NVS
May 15, 2008
Novartis (NVS) opened at $50.98. So far today the stock has hit a low of $50.85 and a high of $51.03. NVS is now trading at $50.80, up 0.67 (1.34%). After hitting a one-year high of $59.17 in January,...
Read More
category
NVS
from
MarketIntelligenceCenter.com
SGX Pharmaceuticals (SGXP) Reports Q1 Profit
May 13, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3640083 for the full story.
Read More
from
StreetInsider.com News Articles
Citi Assumes Coverage on Ophthalmology Names - ACL, AGN, COO and EYE
May 12, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3634645 for the full story.
Read More
from
StreetInsider.com News Articles
The Week in Review: What’s Not to Like in China Biopharma?
May 10, 2008
China-based biopharmas reported higher Q1 revenues and profits last week: American Oriental Bioengineering, Mindray Medical, and Simcere Pharmaceutical all started off the year with new levels of...
Read More
from
ChinaBio® Today
BMP Sunstone Given Go-Ahead for Trials of Enablex®
May 08, 2008
BMP Sunstone Corporation said its Clinical Trial Application for Enablex® (Darifenacin) was accepted by the SFDA, allowing the company to begin clinical trials of the treatment for overactive bladder...
Read More
from
ChinaBio® Today
Novartis AG (NVS) NewsBite
May 06, 2008
Novartis AG ( NYSE: NVS ) closed yesterday at $50.67. So far the stock has hit a 52-week low of $46.19 and 52-week high of $59.17. Novartis AG stock has been showing support around 50.40 and resistance...
Read More
category
NVS
from
MarketIntelligenceCenter.com
Buckingham Research Downgrades Alcon (NYSE: ACL) to Neutral
April 29, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3585988 for the full story.
Read More
from
StreetInsider.com News Articles
Unigene Breaks Ground for China JV Facility
April 24, 2008
Unigene Laboratories, Inc. of Fairfield, NJ has started construction of a facility that will house the operations of its China joint venture, the Unigene Biotechnology Co. Ltd. Unigene owns 45% of the...
Read More
from
ChinaBio® Today
Morgan Stanley Upgrades Novartis (NVS) to Overweight
April 18, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3556729 for the full story.
Read More
from
StreetInsider.com News Articles
Abbott Labs Finally Turns Potential Into Profit
April 17, 2008
Solid numbers for the last two quarters could change Abbott Labs's reputation as an overvalued stock.
Read More
from
Investopedia Advisor Commentary
Novartis AG (NVS) NewsBite
April 16, 2008
Novartis AG ( NYSE: NVS ) closed yesterday at $46.67. So far the stock has hit a 52-week low of $46.36 and 52-week high of $59.17. Novartis AG stock has been showing support around 45.93 and resistance...
Read More
category
NVS
from
MarketIntelligenceCenter.com
Micromet (MITI) Announces Presentations From AACR in San Diego
April 14, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3543109 for the full story.
Read More
from
StreetInsider.com News Articles
Novartis (NVS): Aclasta Beats Sanofi's (SNY) Actonel In Bone Trial - DJ
April 11, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3538461 for the full story.
Read More
from
StreetInsider.com News Articles
PDI (PDII) In Sales Agreement With Novartis Pharmaceuticals
April 11, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3538083 for the full story.
Read More
from
StreetInsider.com News Articles
Novartis' Eye-Catching Deal Won't Add Value
April 08, 2008
Novartis is spreading itself too thin with yet another acquisition - this time for vision specialist Alcon.
Read More
from
Investopedia Advisor Commentary
HSBC Upgrades Novartis (NVS) to Neutral
April 08, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3527119 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
...
65
66
67
68
69
70
71
72
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here